Related Experiment Videos

The involvement of NRF2 in lung cancer

Alison K Bauer1, Thomas Hill, Carla-Maria Alexander

  • 1Department of Environmental and Occupational Health, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. alison.bauer@ucdenver.edu

Oxidative Medicine and Cellular Longevity
|April 12, 2013
PubMed

Insights

Nuclear factor, erythroid-derived 2, like 2 (NRF2) impacts lung cancer development and treatment. Its role is complex, influenced by mutations and cancer stage, affecting therapeutic outcomes.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cellular Stress Response

Background:

  • Nuclear factor, erythroid-derived 2, like 2 (NRF2) is a master regulator of antioxidant and cellular protection mechanisms.
  • The involvement of NRF2 in pulmonary neoplasia is intricate, influenced by specific genetic mutations and the stage of cancer progression.
  • Pulmonary neoplasia currently lacks sufficient reliable biomarkers, highlighting the need for deeper understanding of key regulatory pathways.

Purpose of the Study:

  • To elucidate the multifaceted role of NRF2 in pulmonary neoplasia.
  • To analyze the impact of NRF2 and KEAP1 mutations on lung cancer development and therapeutic responses.
  • To review current and potential therapeutic strategies targeting the NRF2 pathway in lung cancer.

Main Methods:

  • Review of studies on human NRF2 and proposed mechanisms.
  • Analysis of data from various NRF2-deficient mouse models.
  • Examination of xenograft models and chemotherapeutic strategies involving the NRF2 pathway.

Main Results:

  • NRF2's role in lung cancer is context-dependent, significantly affected by activating NRF2 mutations or KEAP1 loss-of-function mutations.
  • Therapeutic interventions targeting NRF2 have yielded variable outcomes, with both anti- and pro-tumorigenic effects observed.
  • The efficacy of NRF2-targeted therapies appears strongly correlated with the specific mutation status of NRF2 or KEAP1.

Conclusions:

  • NRF2's complex role in pulmonary neoplasia necessitates careful consideration of genetic background and cancer stage.
  • Understanding NRF2 mutation status is critical for predicting the efficacy of NRF2-targeted lung cancer therapies.
  • Further research into NRF2-driven mechanisms and targeted therapies holds promise for improving lung cancer treatment outcomes.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...